Shares of U.S. drugmakers fell on Monday after reports that the Food and Drug Administration's top vaccine official, Peter ...

An exclusive report by The Wall Street Journal details how Microsoft unveiled OpenAI's unreleased GPT-4 to the world without ...

Kennedy Jr., a longtime and visceral critic of pharmaceutical and biotech companies, was nominated by President Trump to be ...

The Town of Tonawanda has formally accused members of its police force of violating the state's Taylor Law by participating ...

Commissioner Marty Makary signed off on the plan to push out the agency’s top vaccine official, Peter Marks, in one of his ...

Ouster's growth potential, competitive edge, and strong financial outlook make it a top buy, with a $27 target. Learn why ...

The ice cream giant accused its parent company of removing its CEO because of his support for the brand’s activism.

Tesla CEO Elon Musk reportedly plans to step back from his role in Trump administration. But the DOGE head has denied the ...

It's not yet been a week since Marty Makary, M.D., was confirmed to lead the FDA as its commissioner. | Peter Marks, M.D., Ph ...

On Monday, Ouster stock earned a positive adjustment to its Relative Strength (RS) Rating, from 80 to 95. IBD's proprietary RS Rating identifies technical performance by using a 1 (worst ...

Hailed for his offensive talents, he quickly became the Rangers’ top prospect after the organization drafted him No. 23 ...

After the ouster of Bangladesh Prime Minister Sheikh Hasina, religious fundamentalists in one town announced that young women ...